John Garber promoted to CEO of Elucid Bioimaging

February 13, 2017

February 10, 2017


The Board of Directors of Elucid Bioimaging announce that they have promoted John Garber to Chief Executive Officer, effective February 14, 2017. John’s mission will be the commercial launch of Elucid’s imaging biomarkers business and its expansion into the immune oncology space. As of this date, Elucid’s founder, Andrew Buckler will retain his role of President and assume the duties of Chief Technology Officer to continue to serve the company through his deep technical, industry and standards expertise.

John Garber, has over 25 years of experience in the software industry and 15 in the medical imaging industry. Most recently, he was Vice-President for Imaging Solutions, North America for UK-based Image Analysis Ltd, and prior to that he served as founding CEO of VIDA Diagnostics, a long-time leader in the pulmonary imaging space.

Garber holds a BA in Computer Science from Yale University and an MBA from the University of Chicago. He started his career at Motorola where he held a variety of global product management, sales, and marketing positions in high-growth telecom business units and at the corporate strategy office. Following Motorola, he served as Chief Operating Officer for B2B e-commerce innovator Click Commerce and as Vice President for e-Commerce for PepsiCo.

Andrew Buckler, Founder and current CEO of Elucid said: “John’s business development and commercialization expertise will be critical to the continued growth of Elucid’s contributions to the biotech eco-system.”

John Garber added: “I am very honored and excited to become CEO of Elucid, a bio-informatics company with unique and significant imaging intellectual property. I am highly motivated to lead Elucid’s efforts in creating, validating and qualifying the imaging biomarkers needed for regulatory agency and payer acceptance of new treatments. Our team’s passion to drive imaging advancements for the benefit of patients is inspiring.”

About Elucid Bioimaging

Elucid, based in Wenham, MA, specializes in advanced imaging technology for the development of new therapies and imaging companion diagnostics.